Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2006Pathophysiology of Haemostasis and Thrombosis

Cancer and Venous Thromboembolism. Clinical Implications of Strong Association

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with cancer at risk for or with venous thromboembolism, and patients with idiopathic venous…

Design

Review

Authors

PPPaolo Prandoni

Discussion

Loading...

Member takes

Overview

Supports LMWH preference in cancer VTE; leaves open optimal malignancy screening in idiopathic cases.

Structured PICO

P
Population
Patients with cancer at risk for or with venous thromboembolism, and patients with idiopathic venous thromboembolism
I
Intervention
Low-molecular weight heparins for prophylaxis and treatment; screening for occult malignancies

This review highlights the critical role of low-molecular weight heparins in managing cancer-associated VTE and notes the high prevalence of occult malignancy in idiopathic VTE.

Cite This Study

Paolo Prandoni (2006) studied this question.

synapsesocial.com/papers/6a73956a007d73ca2ffb690dhttps://doi.org/10.1159/000093552
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer-Related Deep Venous Thrombosis: Clinical Importance, Treatment Challenges, and Management Strategies2003 · 61 citations
  2. 2Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy1997 · 104 citations
  3. 3The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism1998 · 626 citations
  4. 4Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis2000 · 755 citations
  5. 5Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism2000 · 327 citations